STOCK TITAN

€950M IQVIA (NYSE: IQV) senior notes planned to refinance debt

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

IQVIA Holdings Inc. announced that its wholly owned subsidiary, IQVIA Inc., plans to raise €950,000,000 through an offering of senior notes due 2033. The company expects to use the proceeds to refinance certain existing indebtedness and to pay related fees and expenses.

The notes will not be registered under the Securities Act and will be offered privately to qualified institutional buyers in the United States under Rule 144A and to non-U.S. investors under Regulation S. Completing the offering is subject to market and other customary conditions and is not yet assured.

Positive

  • None.

Negative

  • None.
Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Senior notes amount €950,000,000 Planned gross proceeds from senior notes due 2033
Maturity year 2033 Maturity of newly offered senior notes
Employees Approximately 93,000 employees Global workforce across more than 100 countries
Global presence Over 100 countries Countries where IQVIA operates
senior notes financial
"intends to raise €950,000,000 through an offering of senior notes due 2033"
Senior notes are a type of loan that a company borrows from investors, promising to pay it back with interest. They are called "senior" because in case the company faces financial trouble, these lenders are paid back before others. This makes senior notes safer for investors compared to other types of loans or bonds.
Rule 144A regulatory
"offered only to persons reasonably believed to be qualified institutional buyers in the United States in reliance on Rule 144A"
Rule 144A is a regulation that makes it easier for companies to sell private bonds to large investors without going through all the usual rules that apply to public sales. It matters because it helps companies raise money more quickly and privately, often attracting big investors looking for special deals.
Regulation S regulatory
"outside the United States only to non-U.S. investors pursuant to Regulation S under the Securities Act"
Regulation S is a set of rules that allows companies to sell securities (like shares or bonds) to investors outside the United States without having to follow all U.S. securities laws. It matters because it makes it easier for companies to raise money from international investors while still complying with U.S. regulations.
qualified institutional buyers financial
"offered only to persons reasonably believed to be qualified institutional buyers in the United States"
Qualified institutional buyers are large organizations, like big investment firms or banks, that are allowed to buy certain types of investment opportunities not available to everyday investors. Their size and experience matter because it ensures they understand and can handle complex financial deals, making markets more efficient and secure.
forward-looking statements regulatory
"Certain statements in this press release are forward-looking statements."
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0001478242 0001478242 2026-06-03 2026-06-03
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 3, 2026

 

 

IQVIA HOLDINGS INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-35907   27-1341991

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

2400 Ellis Road

Durham, North Carolina

  27703
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (919) 998-2000

Not Applicable

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

 

Trading
Symbol

 

Name of Each Exchange

on which Registered

Common Stock, par value $0.01
per share
  IQV   New York Stock Exchange

 

 
 


Item 8.01

Other Events

On June 3, 2026, IQVIA Holdings Inc. (the “Company”) issued a press release announcing that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), intends to raise €950,000,000 in gross proceeds through an offering of senior notes due 2033 and intends to refinance certain of the Issuer’s existing indebtedness. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

 

Item 9.01

Financial Statements and Exhibits

(d) Exhibits.

 

Exhibit
No.

  

Description

99.1    Launch press release dated June 3, 2026
104    Cover Page Interactive Data File (embedded within the Inline XBRL document)

 


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: June 3, 2026

 

IQVIA HOLDINGS INC.
By:  

/s/ Eric M. Sherbet

  Eric M. Sherbet
  Executive Vice President, General Counsel, and Secretary

Exhibit 99.1

IQVIA Announces Offering of Senior Notes

June 3, 2026

RESEARCH TRIANGLE PARK, N.C. – IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), intends to raise €950,000,000 through an offering of senior notes due 2033 (the “Notes”).

The proceeds from the Notes offering will be used to refinance certain of the Issuer’s existing indebtedness and to pay fees and expenses related to the Notes offering. The consummation of the Notes offering is subject to market and other customary conditions.

This press release does not constitute an offer to sell or the solicitation of an offer to buy the Notes, nor shall there be any offer, solicitation or sale of the Notes in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful. The Notes to be offered have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or the securities laws of any other jurisdiction and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act. The Notes are being offered only to persons reasonably believed to be qualified institutional buyers in the United States in reliance on Rule 144A under the Securities Act and outside the United States only to non-U.S. investors pursuant to Regulation S under the Securities Act. Any offer of the Notes will be made only by means of a private offering memorandum.

About IQVIA

IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI®, advanced analytics, the latest technologies and extensive domain expertise. IQVIA is committed to using AI responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance and patient safety, and delivering AI to the high standards of trust, scalability and precision demanded by the industry. With approximately 93,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.

IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures.

Forward Looking Statements

Certain statements in this press release are forward-looking statements. These statements involve a number of risks, uncertainties and other factors, including the failure to consummate the Notes offering, and potential changes in market conditions that could cause actual results to differ materially.

IQVIAFIN

Kerri Joseph, IQVIA Investor Relations (kerri.joseph@iqvia.com)

+1.973-541-3558

FAQ

What did IQVIA (IQV) announce in this 8-K filing?

IQVIA announced that subsidiary IQVIA Inc. plans to issue senior notes to raise €950,000,000. The notes are due 2033, with proceeds intended to refinance existing indebtedness and cover fees and expenses related to the transaction.

How much is IQVIA (IQV) seeking to raise with the new notes?

IQVIA’s subsidiary intends to raise €950,000,000 through an offering of senior notes due 2033. This large issuance is aimed at refinancing certain existing debts and paying associated fees and expenses for the notes offering.

What will IQVIA (IQV) use the senior notes proceeds for?

IQVIA plans to use the proceeds from the €950,000,000 senior notes offering to refinance certain existing indebtedness. Any remaining funds will go toward fees and expenses connected with launching, documenting and completing the notes transaction.

Are IQVIA’s new senior notes registered under the Securities Act?

The senior notes will not be registered under the Securities Act of 1933 or other securities laws. They may be sold only under exemptions, including Rule 144A to qualified institutional buyers and Regulation S to non-U.S. investors via a private offering memorandum.

Who can buy the IQVIA (IQV) senior notes mentioned in the filing?

The notes are being offered only to persons reasonably believed to be qualified institutional buyers in the U.S. under Rule 144A, and to non-U.S. investors outside the United States under Regulation S, through a private offering memorandum.

Is IQVIA’s €950 million senior notes offering guaranteed to close?

The offering is not guaranteed to close; its consummation is subject to market and other customary conditions. The press release also highlights risks, including failure to complete the offering or potential changes in market conditions affecting the transaction.

Filing Exhibits & Attachments

4 documents